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Abstract  
Coronaviruses are enveloped non-segmented positive-sense RNA viruses belonging to the family Coronaviridae and the 
order Nidovirales and broadly distributed in humans and other mammals. The recommendations for the management of 
COVID-19 are mentioned in a lot of Updated Literature such as in The "L. Spallanzani" National Institute for the Infectious 
Diseases. These recommendations are considered as expert's opinions, which may be modified according to newly produced 
literature data. In addition, Chloroquine and its derivative, hydroxychloroquine, have a long history as safe and inexpensive 
drugs for use in malaria-endemic regions and as daily treatments for autoimmune diseases, with the most common side effect 
being eye damage after long-term use.  Although previous studies have revealed that chloroquine has therapeutic activity 
against viruses, including human corona virus OC43 in animal models and SARS-CoV in cell culture studies. we proposed 
that from natural Medicine the polyphenol compounds in olive leaf extracts were responsible for the stimulation of probiotic 
Microbes growth and metabolism and that olive leaf extracts ingested in human diet might have the same effect on desirable 
components of the intestinal microflora, Herbal medicines, plant products, and phototherapeutic have been widely used all 
over the world since ancient times.  Such as Orange, garlic, Bananas, and lemon have an effect on increasing the immune 
system. On the other hand; Gold nanoparticles (AuNPs) are a piece of evidence to treat the harmful responses arising from 
reactive oxygen species (ROS). Silver nanoparticles (AgNPs) are microbial agents which could be potentially used as an 
alternative to anti-viral to treat human infectious disease, especially influenza; there is a novel treatment by using magnetite 
nanoparticles as nanomedicine drug for Covid- 19. 
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Introduction 
The lockdown has started in late 2019,  many 
researchers started  racing to learn more about SARS-
CoV-2, which is one of a family of viruses known as 
coronavirus for their crown-like shape (Acter et al., 
2020).  Northeastern University, Boston, USA, chemical 
engineer Thomas J. Webster, who specializes in 
developing nano-scale Medicine and technology to treat 
diseases, is part of a contingency of scientists that are 
contributing ideas and technology to the Centers for 
Disease Control and Prevention to fight the COVID-19 
outbreak. The concept of using nanoparticles, Webster 
says, is that the virus behind COVID-19 mainly 
constructed of a similar scale as his nanoparticles. At that 
scale, the matter is ultra-small, about ten thousand times 
smaller than the width of a single strand of hair(Hu, 
Frieman, and Wolfram 2020; Liu, Zhou, et al., 2020). 
Webster is proposing particles are similar in sizes that 
could attach to SARS-CoV-2 viruses, concerning their 
structure with a combination of infrared light treatment that 
structural change would then sustained the ability of the 
virus to survive and reproduce in the body. "You have to 
think in this size range," says Webster, Art Zafiropoulo 
Chair of chemical engineering at Northeastern. "In the nano-
scale size range, if you want to detect viruses, you have to 
destroy them." Finding and neutralizing viruses with 
nanomedicine is at the core of what Webster and other 
researchers call theranostics, which focuses on combining 
therapy and diagnosis. Using that approach, his lab has 
specialized in nanoparticles to fight the microbes that cause 
many diseases like influenza and tuberculosis. "It's not just 
having one approach to detect whether you have a virus and 
another approach to use it as a therapy," he says, "but having 
the same particle, the same approach, for both your detection 







In December 2019, a lot of pneumonia cases of 
unknown causes emerged in Wuhan, Hubei, China. 
Following the pneumonia cases were reported in Wuhan and 
shared history of exposure to sea food stores for all COVID -
19 Patient an epidemiological alert and warning was 
released by the local health authority on Dec 2019, more 
than 50 -suspected cases with fever and dry cough were 
transferred to hospitals starting from December 31st, 
2019(Zhu et al., 2020). An expert team consists of 
physicians, Nurses, pharmacist epidemiologists, virologists, 
and government officials who were soon formed after the 
alert. Moreover, according to the National Health 
Commission of China and Ethics Commission of Jin Yin-tan 
Hospital(Yang et al., 2020). The Ethics Commission of the 
designated hospital for prominent infectious diseases.  In 
January 2020, the "World Health Organization" (WHO) 
defined SARS-CoV-2 responsible for the disease (COVID-
19), some of the cases asymptomatic cases to severe 
respiratory involvement(Lai et al., 2020). On March 9th, 
2020, WHO considers that COVID-19 is a global 
pandemic(Downing 2020). Besides, Italy isregarded as the 
second most affected country by COVID-19 infection after 
China. The "L. Spallanzani" National Institute for the 
Infectious Diseases, IRCCS, has been the first Italian 
hospital to admit and manage patients affected by COVID-
19 (Nicastri et al., 2020).  The recommendations for the 
management of COVID-19, as mentioned in the"L. 
Spallanzani" National Institute for the Infectious 
Diseases.These recommendations must be considered as 
expert opinions, which may be modified according to newly 
produced literature data(Nicastri et al., 2020). 
Treatment and Management 
Pharmaceutical Treatments  
According to National Institute for the Infectious 
Diseases "L. Spallanzani", IRCCS. Recommendations for 
COVID-19 clinical management of anti-viral therapy as the 
following; Remdesivir once per day by intravenous route of  
Administration the loading Dose 200 mg, followed by the 
maintenance dose of  100 mg daily withinten days,  or if  
Remdesivir isnot available the suggested Alternative  
Lopinavir/ritonavir* 200/50 mg tablets, two tablets q12h 
within  28 days (Sun 2020), Also Hydroxychloroquine 
phosphate 400 mg tablets loading Dose taken as one tablet 
q12, followed by 200 mg tablets regular Dose 1 tablet q12 
withinten days or we can use Chloroquine phosphate instead 
of Hydroxychloroquine phosphate 250 mg tablets, two 
tablets q12 within ten days (Capalbo et al., 2020). Before Do 
not co-administrate Remdesivir with lopinavir/ritonavir, due 
to possible drug interactions, steroids administration as oral 
or intravenous rehydration and shall be Considered systemic 
in case of clinical signs suggesting an incipient worsening of 
respiratory functions,  the steroids are mandatory if 
Tocilizumab is used  with regimen above   such as 
methylprednisolone 1 mg/Kg daily intravenously for 5 days, 
followed by 40 mg daily for 3 days and, lastly, 10 mg daily 
for 2 days, or dexamethasone 20 mg daily intravenously for 
5 days, followed by 10 mg daily for 3 days and lastly 5 mg 
daily for 2 days(Bowen et al., 2012). Also, an article was 
published regarding the  Artificial intelligence predicts that 
drugs Baricitinib that connected with AP2-related to protein 
kinase 1 (AAK1) affecting and destroying these, proteins 
may inhibit viral entry into the target cells, this Medication 
usually used in the treatment of rheumatoid arthritis, is a 
kinase inhibitor and indicated for controlling viral 
replication. Moreover, the remdesivir, also one in vitro 
clinical study specified that an adenosine analog,which acts 
as a viral protein inhibitor, has improved the condition in 
one patient(Zhang et al., 2020). 
Chloroquine mechanism of action by rising the 
endosomal pH required for virus-cell fusion has the potential 
of blocking viral infection and was shown to affect 
activation of p38 mitogen-activated protein kinase (MAPK), 
which is involved in the replication of HCoV-229E (García 
et al., 2018).When the patient uses a combination of the 
antiretroviral drugs lopinavir and ritonavir, it shows 
significantly improving in the clinical condition of SARS-
CoV patient(González de Requena et al., 2003).This might 
be an option in COVID-19 infections. Further possibilities 
include leronlimab, a humanized monoclonal antibody, and 
galidesivir, a nucleoside RNA polymerase inhibitor, 
andthere maybe will be considered as potential treatment 
candidates(Philippidis 2020). Now almost the Clinical Trials 
focus on the efficacy of remdesivir immunoglobulins, 
arbidol hydrochloride oseltamivir, mesenchymal stem cell 
treatment, hydroxychloroquine, ritonavir plus oseltamivir, 
lopinavir plus ritonavir methylprednisolone and washed 
microbiota transplantation (Velavan and Meyer 2020). 
Another study showed that remdesivir had an excellent 
therapeutic effect (Wu et al., 2020). Now China has carried 
out preliminary clinical trials on this drug. Currently, the 
clinical treatment mainly includes empirical antibacterial 
drugs, intravenous injection of ribavirin for anti-viral and 
appropriate Dose of methylprednisolone to relive the 
shortness of breath U.S (Jin et al., 2020).  In addition, there 
is a suggestion to use traditional Chinese Medicine. This 
property improves the physical signs of patients, as there 
was no critical case; no patient used an invasive ventilator, 
and no death was reported (Wu et al., 2020). 
According to recent reports, more than 85% of patients 
received anti-viral Medication.For example; oseltamivir at a 
dose of 75 mg every 12 h oral route of administration, 
ganciclovir is given 0.25 g every 12 h intravenous route of 
administration and lopinavir/ritonavir tablets was given with 
Dose of 400 mg lopinavir and 100 mg ritonavir twice a day 
orally in combined of the addition of antibiotics that used 
empirically for 90% of patients. Even though using 
intravenous immunoglobulin and systemic steroids have 
been used in several reports in a particularsituation (Lai et 
al., 2020; Gorbalenya et al., 2020; Chen et al., 2020; Huang 
et al., 2020).Also in other reports, several potential drug 
candidates including anti-viral Medication which include the 
following lopinavir and ritonavir, tenofovir disoproxil and 
lamivudine, remdesivir, umifenovir, and chloroquine has 
been well described, including  HIV(Lu 2020) (Wang et al., 
2020; Liu, Morse, et al., 2020; Rolain, Colson, and Raoult 
2007). 
In the current situation, lack of an approved and 
effective vaccine for severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2),the virus causing COVID-19, 
it is essential to evaluate potential prophylactic and 
therapeutic effects of drugs that are clinically approved for 
other indications (Gao, Tian, and Yang 2020). Chloroquine 
and its derivative, hydroxychloroquine, have a long history 
as safe and inexpensive drugs for use in malaria-endemic 






regions and as daily treatments for autoimmune diseases, 
with the most common side effect being eye damage after 
long-term use (Kapoor and Kapoor 2020).  Although 
previous studies have revealed that chloroquine has 
therapeutic activity against viruses, including human 
coronavirus OC43 in animal models and SARS-CoV in cell 
culture studies,  anti-viral mechanisms of chloroquine 
remain speculative (Hu, Frieman, and Wolfram 2020; 
Paraguassu et al., 2020; Salata et al., 2017; SHIQIN 2015). 
Chloroquine has been used in the field of nanomedicine for 
the investigation of nanoparticle uptake in cells, and, 
therefore, insights from synthetic nanoparticle interactions 
with cells in the presence of chloroquine may reveal 
mechanisms that are active at early stages before viral 
replication. Specifically, nanomedicine studies may provide 
clues on chloroquine-induced alterations of SARS-CoV-2 
cellular uptake (Hu, Frieman, and Wolfram 2020) 
Probiotics Treatment 
The best supplement to improve the immune system is 
to take probiotics and prebiotic about one capsule after 
breakfast.This type of supplement will produce compounds 
called immunomodulators to supply the immune system 
cells (Oyetayo and Oyetayo 2005).These compounds work 
to enhance the immune system efficiency against pathogens 
like viruses. It is a supplement that contains microbiota: 
Lactobacillus acidophilus and other species of Lactobacillus 
with Bifidum species. They will be located on colon tissues. 
This treatment not affected directly but enhances the 
immune system to attack the viruses like anyexternal bodies 
inside the human body(Candela et al., 2008). 
Olive leaves implicate high quantities of phenol 
substances very similar to those present in olives and their 
derived products(Ghidan et al., 2018). There is compelling 
scientific evidence that olive leaf polyphenols are bioactive 
compounds. Olive leaves or their specific organic 
constituents has significant antimicrobial(Bisignano et al., 
1999), antioxidant(Ruiz-Gutiérrez et al., 1999) and anti-
inflammatory properties(Briante et al., 2002), 
atherosclerosis inhibition and hypotensive action(Lee et al., 
2009; Omar 2010) and anticarcinogenic properties that lead 
to the prevention of some cancers(Owen et al., 2004). 
Beneficial properties of olive leaf extracts are further 
consolidated by the bioavailability of their polyphenolic 
constituents, which are readily absorbed through the 
gastrointestinal tract, resulting in significant levels in the 
circulation system(Visioli et al., 2000; Vissers et al., 2002).  
In relation to humans, much concernshave been focused 
on phenolic compounds from plants and foods that may 
adjust microbiota in the intestine by selectively increasing 
that growth of  and lactobacilli and decreasing that harmful 
bacteria such as clostridia(Haddadin 2010). The olive leaf 
polyphenol composition is alike to that of olive oil. 
Oleuropein and other secoiridoids are the concept 
combination while simple phenols, enclosed hydroxytyrosol, 
are shown but in lower amounts (Tuck and Hayball 2002). 
Olive leaves consist of  flaronoids such as: rutinflavonol, 
Luteolin-7-glucoside(Pereira et al., 2007).The olive leave 
extract was shown to have an antioxidant capacity 400% 
higher than vitamin C and almost double that of green tea or 
grape seed extracts (Ryan, Robards, and Lavee 1999).  
As asignificance of the high incidence of civilization, 
diseases, Science, and industry direct their interests toward 
the production of food products, which are beyond the 
normal nutritional function, deliver health benefits. These 
products are called functional foods, and the probiotics are 
an example(Fuller 1991; Roberfroid 2000). Recently, the 
developed countries have arrived at a new food formulation, 
originated from the combination of nutraceutical compounds 
and probiotic microorganisms, and formulations are 
mounting quite a trend (De Leonardis et al., 2008).The 
growing popularity of functional food causes increasing 
interest in raw materials, which can raise the  value of food 
when supplemented (Duda-Chodak, Tarko, and Statek 
2008). Different results were obtained regarding the effects 
of plant extracts rich in polyphenolic compounds on the 
growth of probiotic bacteria and other microorganisms. It 
was proved that plant extracts could inhibit the growth of 
food associated with pathogens and microbes. 
Nanotechnology Treatments  
Nonomaterial's (N.M.s) have unique 
physicochemical properties in providing versatile 
scaffolds for functionalization with biomolecules. 
Moreover, certain N.M.s such as gold and magnetic 
nanoparticles as well as polymeric or hybrid N.M.s have 
shown a respond to external stimuli achieving a 
spatiotemporal controlled release of macromolecules 
(Mout et al., 2012; Sapsford et al., 2013). For these 
reasons, over the last two decades, engineered 
nanomaterials have been successfully tested and applied 
in Medicine and pharmacology. Gold nanoparticles 
(AuNPs) are a piece of evidence to treat the harmful 
responses arising from reactive oxygen species (ROS). 
Silver nanoparticles (AgNPs) are microbial agents which 
could be potentially used as an alternative to anti-viral to 
treat human infectious disease, especially influenza. Virus 
infections were unsuccessfully treated by anti-viral 
(Ghidan et al., 2017; Al and Ghidan, 2018; Mariadoss et 
al., 2019).  
However, many concerns about the use of AgNPs on 
humans arise from their potential toxicity, although 
mechanisms are not well-understood. We represent here, 
in the context of influenza virus infection of lung 
epithelial cells, that AgNPs down-regulated influenza 
induced CCL-5 and -IFN-β release (two cytokines 
important in anti-viral immunity) through RIG-I 
inhibition, while enhancing IL-8 production, a cytokine 
important for mobilizing host antibacterial responses 
(Rezvani et al., 2019). AgNPs activity was independent 
of coating, and it was not observed with gold 
nanoparticles.  
Down-stream analysis indicated that AgNPs 
disorganized the mitochondrial network. It prevented the 
anti-viral IRF-7 transcription factor influx into the 
nucleus. Importantly, we represent that the modulation of 
the RIG-I-IRF-7 pathway was concomitant with 
inhibition of either classical or alternative autophagy 
(ATG-5- and Rab-9 dependent) depending on the 
epithelial cell type used (Villeret et al., 2018). Altogether, 
this demonstration of AgNPs-mediated functional 
dichotomy (down-regulation of IFN-dependent anti-viral 
responses and up-regulation of IL-8-dependent 
antibacterial responses) may have practical implications 
for their use in the clinic (Villeret et al., 2018). 
Chloroquine, an approved malaria drug, is known in 






nanomedicine research for the investigation of 
nanoparticle uptake in cells, and it may have the potential 
for the treatment of COVID-19 (Shukla et al., 2020). 
Gold, silver, zinc, and copper nanoparticles can be 
affected by this virus, as well as Magnetite nanoparticles 
(Patient as nano capsulation).  
Natural products and biochemicals  
Eclipta prostrata and known for its therapeutic 
values in the cure of viral infections, human bronchial 
epithelial cell injury. It has many pharmacological 
properties such as anti-inflammatory, anti-cancer, and 
antioxidant activities(Feng et al., 2019; Li and Kan 
2017). 
Immunomodulatory activity of some monoterpenes 
limonene and carvone 
The action of the immunomodulatory activity of 
some monoterpenes was studied on animals like mice—
administration of carvone and limonene like other various 
monoterpenes. The researches indicate the increase of the 
total count of white blood cells (WBC) in mice. The 
maximum total of WBC count in carvone treated mice 
appeared on the 12th day while in limonene was on the 
9th day after the combined administration of carvone and 
limonene increased the total antibody production. 
Antibody producing cells in the spleen, bone marrow 
cellularity (figure 1), and alpha-esterase positive cells 
significantly compared to the healthy animals indicating 
its potentiating effect on the immune system (De 
Carvalho and Da Fonseca 2006; Andrade and De Sousa 








Figure 1: Naturally occurring monoteroenes carvone and 
limonene 
Food and Some Nutritional Elements  
Herbal medicines, plant products, and phototherapeutic 
have been widely used all over the world since ancient 
times.  Such as Orange, garlic, Bananas,and lemon have an 
effect on increasing the immune system (Vanderhaeghe 
2000). Anti-viral properties of garlic were shown in 
vitro activity against influenza A and B (Weber et al. 1992).  
Regarding orange, there is much literature regarding orange 
extracts the results of the provided anti-viral activity. These 
properties suggest that this orange peel could provide 
advantages as a topical prophylactic/therapeutic agent for 
some viral infection (Guo et al., 2012; Marzouk 2013; 
Huang et al., 2015). 
Prevention and Disinfectants 
The most efficient solution to destroy the coronavirus is 
a solution contains the following compounds: 71% ethanol, 
1% hydrogen peroxide and 0.10% Sodium hypo chlorate by 
using as external prevention for cleaning and disinfectant 
(Pradhan et al., 2020) 
Novel treatments  
SARS-CoV-2 escalates mostly through tiny droplets of 
viral particles from breathing, talking, sneezing, 
coughingthat enter the body through the eyes, mouth, and 
nose. Prospective role of inanimate surfaces for the spread of 
coronaviruses and their distraction with disinfectant agents. 
It suggests that those germs may survive for days when they 
attach themselves to countertops, handrails, and other hard 
surfaces (Kingsbury et al. 2020).That's one reason to make 
theranostics with nanoparticles the focus of the COVID-19 
outbreak. Nanoparticles can damage  these pathogens even 
before they break into the body, as they hold on to different 
objects and surfaces(Albrecht, Evans, and Raston 2006). His 
lab has developed materials that can be spattered on objects 
to form nanoparticles and attack viruses. 
"Even if it was on a surface, on someone's countertop, 
or a mobilephone," he says. "It doesn't mean anything 
because it's not the active form of that virus.That same 
technology can be fine-tuned and changed to target a wide 
range of viruses, bacteria, and other pathogens. Unlike other 
novel drugs with large molecular structures, nanoparticles 
are so small that they can move through our body without 
disrupting other functions, such as those of the immune 
system. 
"Almost like a surveyor, they can go around your 
bloodstream," Webster says. "They can survey your body 
much easier and under much longer times and try and detect 
viruses." To do all that, the Centers for Disease Control and 
Prevention (CDC) need to know the specifics about what 
kind of structure is required to neutralize SARS-CoV-2, 
Webster says.   
An alternative to nanomedicine is producing synthetic 
molecules. But Webster says that tactic presents some 
challenges(Alvarez et al., 2017). In the case of 
chemotherapies used to treat cancer cells, such synthetic 
drugs can cause severe side effects that kill cancer cells, as 
well as other cells in the body (Sak 2012). The same thing 
could be happening with synthetic chemistry to treat a virus, 
where molecules are killing a lot more than just that virus 
(Wimmer et al., 2009).  Webster says. Still, Webster 
acknowledges that there aren't many researchers focusing on 
nanoparticles to kill microorganisms.  One of the main 
reasons for the lack of those solutions is that the same 
benefits that make nanoparticles ideal to fight infectious 
diseases also make them a concern for the U.S. Federal Drug 
Administration. Because of their size, nanoparticles are 
extensive  to seep through other parts of the body (Buzea, 
Pacheco, and Robbie 2007; Ratner and Ratner 2004). To 
decrease that risk, Webster's lab has focused on using iron 
oxide. Particles of that makeup entail chemistry that is 
already natural to our bodies and diets. 
Even if you have a viral infection, you need more iron, 
because you could be anemic depending on how bad the 
infection is. "We're developing these nanoparticles out of 
chemistries that can help your health. Iron-based 
nanoparticles could be directed with magnetic fields to target 
specific organs in the body, such as lungs and other areas 
susceptible to respiratory complications after contracting 
viral infections (Ratner and Ratner 2004; Greish et al., 






2018). That too, Webster says, is something that you 
couldn't do with a novel synthetic molecule. What this all 
means is that we just have to do the studies to show those 
iron nanoparticles are not going into the brain or the kidney 
and that these nanoparticles are going exactly where you 
want them to go to the virus. 
Expected Medication to treat corona virus  
First family:Antimalaria  
Chloroquine:  
It used for the treatment of acute malaria. As 
chemoprophylaxis also the mod of action  (MOA) binds to 
and inhibits DNA and RNA polymerase interferes with 
metabolism and hemoglobin utilization by parasites inhibits 
prostaglandin effects, chloroquine concentrates within 
parasite acid vesicles. It raises internal pH resulting in 
inhibition of parasite growth, andit may involve aggregates 
of ferriprotoporphyrin IX acting as chloroquine receptors 
causing membrane damage that may also interfere with 
nucleoprotein synthesis (Wellems and Plowe 2001; Krogstad 
et al., 1987; Trape et al. 1998). The proposed mechanism 
involves chloroquine-induced suppression of PICALM, 
which prevents endocytosis-mediated uptake of SARS-CoV-
2 '5 
Quinine  
It was conjunction with other antimalaria, and for 
uncomplicated chloroquine-resistant P. falciparum malaria, 
MOA depresses oxygen uptake and carbohydrate 
metabolism, intercalates into DNA disrupting the replication 
and transcription of the parasites, cardiovascular effects 
similar to quinidine(Krishna and White 1996; Denes, 
Gabster, and Huang 1981). 
Second family:Antiviral  
Amantadine 
As an anti-viral agent and anti-Parkinson's agent, the 
MOA as anti-viral blocks the uncoating of influenza A virus, 
preventing the penetration of the virus into host.As anti 
Parkinsoninactivity may be due to it's blocking the reuptake 
of dopamine into presynaptic neurons or by increasing 
dopamine release from presynaptic fibers(Davies et al., 
1964; Staničova, Miškovsky, and Šutiak 2001). 
Rimantadine 
Prophylaxis adult and children > 1 and treatment for an 
adult of influenza A viral infection (45), the MOA exerts its 
inhibitory effect on three antigenic subtypes of influenza a 
virus (H1N1, H2N2, H3N2 ) early in the viral explicative 
cycle possibly inhibiting the uncoating process it has no 
activity against influenza B virus, 2-8fold more active than 
amantadine(Tominack and Hayden 1987; Jefferson et al., 
2002). On the other hand, the researchers found that the 
molecular bond between SARS-CoV-2's spike protein and 
ACE2 looks fairly similar to the binding pattern of the 
coronavirus that caused the outbreak of SARS in 
2003(McNamara, Richt, and Glickman 2020). There are 
some differences, and however, in the precise amino acids 
used to bind SARS-CoV-2 to that ACE2 receptor compared 
with the virus that causes SARS (severe acute respiratory 
syndrome), this Medication maybe can use to treat coved 19 
(Denis et al., ; Prabakaran, Xiao, and Dimitrov 2004). 
Conclusion 
Chloroquine and its derivative, hydroxychloroquine, 
have a long history as safe and inexpensive drugs for use in 
malaria-endemic regions and as daily treatments for 
autoimmune diseases, with the most common side effect 
being eye damage after long-term use (Kapoor and Kapoor 
2020).  Although previous studies have revealed that 
chloroquine has therapeutic activity against viruses, 
including human coronavirus OC43 in animal models and 
SARS-CoV in cell culture studies, Herbal medicines, plant 
products, and phototherapeutic have been widely used all 
over the world since ancient times.  Such as Orange, garlic, 
Bananas, and lemon have an effect on increasing the 
immune system. Silver nanoparticles (AgNPs) are microbial 
agents which could be potentially used as an alternative to 
anti-viral to treat human infectious disease, especially 
influenza; there is a novel treatment by using magnetite 
nanoparticles as nanomedicine drug for Covid- 19. 
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